C. Ronald Kahn

Chief Academic Officer at Joslin Diabetes Center at the Harvard Stem Cell Institute

C. Ronald Kahn

C. Ronald Kahn

Chief Academic Officer at Joslin Diabetes Center at the Harvard Stem Cell Institute

Overview
Career Highlights

Ember Therapeutics, Inc. (Inactive)

RelSci Relationships

697

Number of Boards

10

Contact Data
Trying to get in touch with C. Ronald Kahn? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals C. Ronald Kahn likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Medical Officer & Senior Vice President at Joslin Diabetes Center at the Harvard Stem Cell Institute

Relationship likelihood: Strong

Professor of the Division of Endocrinology, Department of Medicine at University of Pennsylvania - Perelman School of Medicine

Relationship likelihood: Strong

Founder at Cohbar, Inc.

Relationship likelihood: Strong

Founder at J Hopfield Consulting

Relationship likelihood: Strong

Chairman at Joslin Diabetes Center at the Harvard Stem Cell Institute

Relationship likelihood: Strong

Former President-Long Island Leadership Council at American Diabetes Association, Inc.

Relationship likelihood: Strong

Senior Vice President & General Counsel at Enanta Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive Director at Commonwealth of Massachusetts Group Insurance Commission

Relationship likelihood: Strong

Vice President of Engineering, Technology & Mission Assurance at Raytheon Company

Relationship likelihood: Strong

Founder at CeQur SA

Relationship likelihood: Strong

Paths to C. Ronald Kahn
Potential Connections via
Relationship Science
You
C. Ronald Kahn
Chief Academic Officer at Joslin Diabetes Center at the Harvard Stem Cell Institute
Education

Louisiana State University and Agricultural and Mechanical College (most often referred to as Louisiana State University or LSU) is a public coeducational university located in Baton Rouge, Louisiana.[7] The University was founded in 1853 in what is now known as Pineville, Louisiana, under the name Louisiana State Seminary of Learning & Military Academy. The current LSU main campus was dedicated in 1926, and consists of more than 250 buildings constructed in the style of Italian Renaissance architect Andrea Palladio, and occupies a 650-acre (2.6 km²) plateau on the banks of the Mississippi River.

The University of Louisville is a state supported research university located in Kentucky's largest metropolitan area. It was a municipally supported public institution for many decades prior to joining the university system in 1970. The University has three campuses. The 287-acre Belknap Campus is three miles from downtown Louisville and houses seven of the university's 12 colleges and schools. The Health Sciences Center is situated in downtown Louisville's medical complex and houses the university's health related programs and the University of Louisville Hospital. The 243-acre Shelby Campus is located in eastern Jefferson County.

Doctor of Medicine Unknown

With over 40,000 students and more than 9,000 employees, the University of Copenhagen is the largest institution of research and education in Denmark. The purpose of the University – to quote the University Statute – is to ’conduct research and provide further education to the highest academic level’.

University of Geneva is a public research university located in Geneva, Switzerland.

Founded in 1861 by a private gift of 10 acres in what is now the heart of downtown Seattle, the UW is one of the oldest public universities on the West Coast. We’re deeply committed to upholding the responsibility that comes with that legacy. And being public has always meant being accessible. Anyone can enjoy and be enriched by all the UW has to offer, including world-class libraries, art, music, drama, sports and the highest quality medical care in Washington state. Being public also means being engaged with our communities, and through knowledge and discovery we are elevating the quality of lives of others.

Career History
Chief Academic Officer
1981 - Current

Joslin Diabetes Center develops pharmaceuticals for diabetes. The firm develops and disseminates patient therapies and scientific discoveries throughout the world. The company was founded in 1898 and is headquartered in Boston, MA.

Founder
2011 - Prior

Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY.

Mary K. Iacocca Professor of Medicine
Current

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

Boards & Committees
Member, Scientific Advisory Board
2014 - Current

Rezolute, Inc. is biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.

Member, Advisory Board-Endocrinology
Current

LifeMed Media, Inc. provides multimedia healthcare marketing services. It operates an online community network and resource for diabetes patients, their caregivers, and healthcare providers. The company was founded in 2004 and is headquartered in Westport, CT.

Member, Scientific Advisory Board
Current

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.

Member, Scientific Advisory Board
Current

The Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA.

Member, Board of Directors
Current

American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA.

Trustee
Prior

Joslin Diabetes Center develops pharmaceuticals for diabetes. The firm develops and disseminates patient therapies and scientific discoveries throughout the world. The company was founded in 1898 and is headquartered in Boston, MA.

Investments
Details Hidden

Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by C. Ronald Kahn. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of C. Ronald Kahn's profile does not indicate a business or promotional relationship of any kind between RelSci and C. Ronald Kahn.